[Aluminum and iron deposition in dialysis patients].
Kashiwagi
Tetsuya
T
Second Department of Internal Medicine, Nippon Medical School.
Kurihara
Satoshi
S
D000535:Aluminum / Q000378:metabolism*; D000536:Aluminum Hydroxide / Q000009:adverse effects; D000740:Anemia / Q000209:etiology; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism* / Q000628:therapy; D000075202:Contraindications; D003676:Deferoxamine / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis / Q000209:etiology; D003937:Diagnosis, Differential; D003956:Dialysis / Q000009:adverse effects*; D006801:Humans; D007501:Iron / Q000378:metabolism*; D010018:Osteomalacia / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism* / Q000628:therapy
D000536:Aluminum Hydroxide; D000535:Aluminum; D007501:Iron; D003676:Deferoxamine